Peter Kolchinsky latest buys and sells
17 complete sales in Peter Kolchinsky's latest 13F filing, largest first. The largest is the sale of the whole position in DNTH, $219.2M or 1.9% of the reported portfolio.
Key facts
- Complete sales
- 17
- Largest move
- DNTH, $219.2M
- Latest filing
- Aug 14, 2026
From RA Capital Management's filing for (Q2 2026), filed , against the filing for Mar 31, 2026.
| # | Stock | Move | Shares | Size | Of portfolio |
|---|---|---|---|---|---|
| 1 | Dianthus Therapeutics IncDNTH | ▼ Sold out | — | $219.2M | 1.90% |
| 2 | Praxis Precision MedicinesPRAX | ▼ Sold out | — | $120.4M | 1.05% |
| 3 | Sarepta Therapeutics IncSRPT | ▼ Sold out | — | $84.9M | 0.74% |
| 4 | Spyre Therapeutics IncSYRE | ▼ Sold out | — | $81.8M | 0.71% |
| 5 | Fulcrum Therapeutics IncFULC | ▼ Sold out | — | $46.4M | 0.40% |
| 6 | Olema Pharmaceuticals IncOLMA | ▼ Sold out | — | $38.8M | 0.34% |
| 7 | Design Therapeutics IncDSGN | ▼ Sold out | — | $31.6M | 0.27% |
| 8 | Travere Therapeutics IncTVTX | ▼ Sold out | — | $22.2M | 0.19% |
| 9 | Grail IncGRAL | ▼ Sold out | — | $22.1M | 0.19% |
| 10 | Relmada Therapeutics IncRLMD | ▼ Sold out | — | $20.5M | 0.18% |
| 11 | Sutro Biopharma IncSTRO | ▼ Sold out | — | $17.8M | 0.15% |
| 12 | Contineum Therapeutics IncCTNM | ▼ Sold out | — | $16.9M | 0.15% |
| 13 | Inspire Med Systems IncINSP | ▼ Sold out | — | $16.8M | 0.15% |
| 14 | Hinge Health IncHNGE | ▼ Sold out | — | $14.1M | 0.12% |
| 15 | GeneDx Holdings CorpWGS | ▼ Sold out | — | $13.5M | 0.12% |
| 16 | Atrium Therapeutics IncRNA | ▼ Sold out | — | $11.6M | 0.10% |
| 17 | Maplight Therapeutics IncMPLT | ▼ Sold out | — | $5M | 0.04% |
Questions and answers
What did Peter Kolchinsky sell last quarter?
The largest sales in the latest 13F filing: DNTH, $219.2M; PRAX, $120.4M; SRPT, $84.9M; SYRE, $81.8M; FULC, $46.4M; OLMA, $38.8M.
How is the size of a buy or sell worked out?
As the change in shares at the price the filing implies for the quarter's end (reported value divided by shares) — an estimate of the trade, not what was paid. A position sold out is sized at its value in the previous filing.
Learn
Cite this page
Funkfolio, “Peter Kolchinsky: buys and sells, Q2 2026 13F”, data as of 14 August 2026. https://funkfolio.com/gurus/activity?type=sold&investor=peter-kolchinsky
Underlying data: SEC EDGAR, Form 13F-HR.
Source: SEC EDGAR, Form 13F-HR. A move is a change in share count between an investor's latest filing and the one before; a share split in between is allowed for where one is on record. Size is the shares bought or sold at the price the filing implies for the period end (reported value ÷ shares) — an estimate of the trade, not what was paid — and a position sold out is sized at its value in the previous filing. “Of portfolio” sets that size against the portfolio reported for the period. Only each investor's 150 largest positions and 50 largest exits are read. Filings appear up to 45 days after the quarter ends; none of this is advice.